WW claims that in a real-world comparative analysis, its members achieved 72% greater average weight loss than a cohort receiving compounded GLP-1 medications through Hims & Hers
Boehringer Ingelheim International GmbH (Emerging Leader) is classified as a rapidly emerging leader, with a focus on developing a novel GLP-1 agonist (Survodutide) in phase 3 of clinical development
Betz RC, Petukhova L, Ripke S, Huang H, Menelaou A, Redler S, Becker T, Heilmann S, Yamany T, Duvic M, Hordinsky M, Norris D, Price VH, Mackay-Wiggan J, de Jong A, DeStefano GM, Moebus S, Bhm M, Blume-Peytavi U, Wolff H, Lutz G, Kruse R, Bian L, Amos CI, Lee A, Gregersen PK, Blaumeiser B, Altshuler D, Clynes R, de Bakker PIW, Nthen MM, Daly MJ, Christiano AM (2015) Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci
Purity without identity High percentage purity is only meaningful when you know exactly what is being measured
The advantage of food fortification is, compared with supplementation, that there is no need to change dietary habits 121,122,194,233,333,580,581,596,631,636,637,638,639,640,641,642,643,644,645,646,647,648,649,650,651,652,653,654,655,656,657,658,659,660,661,662,663,664,665,666,667,668,669,670,671,672,673,674,675,676,677,678,679,680,681,682,683,684,685,686,687,688
